Most degenerative diseases are driven by chronic, sub-clinical inflammation. The old view of the inflammation is that it represents the healing process. This is true to a certain extent; however when the inflammation becomes chronic, it becomes a disease.

Today the study of inflammation has gone from the tissue levels deeper into the nuclear level. Cell-signaling molecules have been identified which stimulate the gene that induce the expression of the COX enzyme, which in turn induce inflammation.

 

Nuclear Factor-ĸB: The Master Regulator of Inflammation

Nuclear Factor-Kappa B (NF-ĸB), as the ‘master switch’, is the primary means by which inflammation is ‘adjusted’.

 

  • In the normal state NF-ĸB resides in the cytoplasm of the cell and is bound to its inhibitor—IkB (Inhibitor of ĸB)
  • Injuries and inflammatory stimuli, such as free radicals trigger the release NF- ĸB from IkB
  • The free NF-ĸB, now moves into the nucleus and activates the genes responsible for expressing cyclooxygenase-2 (COX-2)
  • This leads to inflammation

NF-ĸB activation is a major mediator of inflammation in most diseases and inhibition of NF-ĸB can help prevent/delay the onset of the disease. Curcuminoids―natural compounds derived from turmeric roots, inhibit NF-ĸB.

Inflammation plays a major role in development of most diseases

About Sabinsa

Sabinsa Corporation is a manufacturer, supplier and marketer of herbal extracts, cosmeceuticals, minerals, dietary supplements and specialty fine chemicals for the nutritional, cosmetic, pharmaceutical and food industries.

Read More..

HeadQuarters

Sabinsa Corporation

20 Lake Drive 

East Windsor, NJ 08520, USA

Tel: +1.732.777.1111

Fax: +1.732.777.1443

This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Contact Presence